title: Mycetoma medical therapy.
abstract: Medical treatment of mycetoma depends on its fungal or bacterial etiology. Clinically, these entities share similar features that can confuse diagnosis, causing a lack of therapeutic response due to inappropriate treatment. This review evaluates the response to available antimicrobial agents in actinomycetoma and the current status of antifungal drugs for treatment of eumycetoma.
authors.affiliation: Department of Dermatology, Dr. Jose E. Gonzalez University Hospital, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
authors.forename: Oliverio
authors.initials: O
authors.lastname: Welsh
authors.affiliation: Section of Infectious Diseases, Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
authors.forename: Hail Mater
authors.initials: HM
authors.lastname: Al-Abdely
authors.affiliation: Department of Immunology, Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
authors.forename: Mario Cesar
authors.initials: MC
authors.lastname: Salinas-Carmona
authors.affiliation: The Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan.
authors.forename: Ahmed Hassan
authors.initials: AH
authors.lastname: Fahal
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D006801:Humans; D008826:Microbial Sensitivity Tests; D008271:Mycetoma / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000890:Anti-Infective Agents; D000935:Antifungal Agents